4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Eurofins Scientific SE (ERF) operates in the Diagnostics & Research industry and is headquartered in Luxembourg, Luxembourg with about 65,000 employees. Its market capitalization is roughly €12 billion. In the fiscal year ended 2025-12-31, ERF reported €7.3B in revenue and €475M in net income.
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €7.3B | €7.0B | €6.5B | €6.7B | — |
| Gross Profit | €5.0B | €4.7B | €4.4B | €4.5B | — |
| Operating Income (EBIT) | €818M | €726M | €547M | €783M | — |
| Net Income | €475M | €406M | €310M | €610M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€108M) | (€96M) | (€192M) | (€192M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €11.0B | €10.9B | €10.9B | €10.1B | — |
| Total Liabilities | €6.4B | €5.5B | €5.8B | €5.2B | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ERF viewer.
About TickerBase · Data methodology & sources · Privacy · Terms